Literature DB >> 10629766

Free PKC catalytic subunits (PKM) phosphorylate tau via a pathway distinct from that utilized by intact PKC.

F J Ekinci1, T B Shea.   

Abstract

Protein kinase C (PKC) is reversibly activated at the plasma membrane by the generation of diacylglycerol (DAG) coupled with the release of Ca2+ from intracellular stores. PKC is also irreversibly activated by calpain-mediated PKC cleavage of the regulatory and catalytic subunits; resultant free PKC catalytic subunits are termed "PKM". Unlike PKC, PKM is co-factor-independent, remains active following diffusion away from the membrane, and can theoretically phosphorylate targets inaccessible to, and inappropriate for, PKC. We examined the downstream consequences of PKC activation by the phorbol ester TPA and by ionophore A23187-mediated calcium influx (which experimentally correspond to DAG-mediated and calpain-mediated activation, respectively) on phosphorylation of the microtubule-associated protein tau. Both methods increased phospho-tau immunoreactivity, and neither was inhibited by lithium or olomoucin (inhibitors of tau kinases GSK-3 beta and cdk5, respectively). The TPA-mediated increase, and not the ionophore-mediated increase, was blocked by co-treatment with the mitogen-activated protein (MAP) kinase kinase inhibitor PD98059. These findings indicate that PKC phosphorylates tau via the MAP kinase pathway, but that PKM can bypass this requirement, therefore demonstrating that distinct intracellular pathways can be mediated by PKC and PKM. PKM generation may therefore trigger one or more additional pathways contributing to tau phosphorylation following inappropriate calcium influx.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10629766     DOI: 10.1016/s0006-8993(99)02146-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Genome wide profiling of dopaminergic neurons derived from human embryonic and induced pluripotent stem cells.

Authors:  Olga Momčilović; Qiuyue Liu; Andrzej Swistowski; Tatiane Russo-Tait; Yiqiang Zhao; Mahendra S Rao; Xianmin Zeng
Journal:  Stem Cells Dev       Date:  2013-11-07       Impact factor: 3.272

Review 2.  Calpain Inhibitors as Potential Therapeutic Modulators in Neurodegenerative Diseases.

Authors:  Heena Khan; Nikhil Garg; Thakur Gurjeet Singh; Amarjot Kaur; Komal Thapa
Journal:  Neurochem Res       Date:  2022-01-04       Impact factor: 3.996

3.  Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease.

Authors:  Takahide Kaji; Barry Boland; Tatjana Odrljin; Panaiyur Mohan; Balapal S Basavarajappa; Corrinne Peterhoff; Anne Cataldo; Anna Rudnicki; Niranjana Amin; Bing Sheng Li; Harish C Pant; Basalingappa L Hungund; Ottavio Arancio; Ralph A Nixon
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

4.  Age-related calcium dysregulation linked with tau pathology and impaired cognition in non-human primates.

Authors:  Dibyadeep Datta; Shannon N Leslie; Min Wang; Yury M Morozov; Shengtao Yang; SueAnn Mentone; Caroline Zeiss; Alvaro Duque; Pasko Rakic; Tamas L Horvath; Christopher H van Dyck; Angus C Nairn; Amy F T Arnsten
Journal:  Alzheimers Dement       Date:  2021-04-07       Impact factor: 21.566

5.  Synergy analysis reveals association between insulin signaling and desmoplakin expression in palmitate treated HepG2 cells.

Authors:  Xuewei Wang; Aritro Nath; Xuerui Yang; Amanda Portis; S Patrick Walton; Christina Chan
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

6.  Fine-scale haplotype mapping of MUT, AACS, SLC6A15 and PRKCA genes indicates association with insulin resistance of metabolic syndrome and relationship with branched chain amino acid metabolism or regulation.

Authors:  Sara Haydar; Florin Grigorescu; Mădălina Vintilă; Yannick Cogne; Corinne Lautier; Yildiz Tutuncu; Jean Frederic Brun; Jean Marie Robine; Michel Pugeat; Christophe Normand; Patrick Poucheret; Monica Livia Gheorghiu; Carmen Georgescu; Corin Badiu; Nicoleta Băculescu; Eric Renard; Dorina Ylli; Stephanie Badiou; Thibault Sutra; Jean Paul Cristol; Jacques Mercier; Ramon Gomis; Josep Maria Macias; Serghey Litvinov; Elza Khusnutdinova; Catalina Poiana; Renato Pasquali; Davide Lauro; Giorgio Sesti; Sabrina Prudente; Vincenzo Trischitta; Agathocles Tsatsoulis; Sonia Abdelhak; Abdelhamid Barakat; Akila Zenati; Agron Ylli; Ilhan Satman; Timo Kanninen; Yves Rinato; Sasa Missoni
Journal:  PLoS One       Date:  2019-03-26       Impact factor: 3.752

7.  Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease.

Authors:  Isidro Ferrer; Pol Andrés-Benito; Karina Ausín; Reinald Pamplona; José Antonio Del Rio; Joaquín Fernández-Irigoyen; Enrique Santamaría
Journal:  Brain Pathol       Date:  2021-07-04       Impact factor: 6.508

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.